Toxicology and Epidemiology: Improving the Science with a Framework for Combining Toxicological and Epidemiological Evidence to Establish Causal Inference

Historically, toxicology has played a significant role in verifying conclusions drawn on the basis of epidemiological findings. Agents that were suggested to have a role in human diseases have been tested in animals to firmly establish a causative link. Bacterial pathogens are perhaps the oldest examples, and tobacco smoke and lung cancer and asbestos and mesothelioma provide two more recent examples. With the advent of toxicity testing guidelines and protocols, toxicology took on a role that was intended to anticipate or predict potential adverse effects in humans, and epidemiology, in many cases, served a role in verifying or negating these toxicological predictions. The coupled role of epidemiology and toxicology in discerning human health effects by environmental agents is obvious, but there is currently no systematic and transparent way to bring the data and analysis of the two disciplines together in a way that provides a unified view on an adverse causal relationship between an agent and a disease. In working to advance the interaction between the fields of toxicology and epidemiology, we propose here a five-step “Epid-Tox” process that would focus on: (1) collection of all relevant studies, (2) assessment of their quality, (3) evaluation of the weight of evidence, (4) assignment of a scalable conclusion, and (5) placement on a causal relationship grid. The causal relationship grid provides a clear view of how epidemiological and toxicological data intersect, permits straightforward conclusions with regard to a causal relationship between agent and effect, and can show how additional data can influence conclusions of causality.

[1]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[2]  J. Swenberg,et al.  alpha 2-Urinary globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats. , 1999, IARC scientific publications.

[3]  Michael S Victoroff,et al.  Evidence-based toxicology: a comprehensive framework for causation , 2005, Human & experimental toxicology.

[4]  F. Speizer,et al.  Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. , 1996, The New England journal of medicine.

[5]  Chien-Jen Chen,et al.  Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan , 1996, International journal of cancer.

[6]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[7]  T. Pastoor,et al.  Historical perspective of the cancer bioassay. , 2005, Scandinavian journal of work, environment & health.

[8]  Ames,et al.  Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. , 2000 .

[9]  Alan R. Boobis,et al.  IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans , 2006 .

[10]  K. Popper,et al.  The Logic of Scientific Discovery , 1960 .

[11]  M Younes,et al.  IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.

[12]  A. B. Hill The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[13]  A. Boobis,et al.  The Key Events Dose-Response Framework: A Cross-Disciplinary Mode-of-Action Based Approach to Examining Dose-Response and Thresholds , 2009, Critical reviews in food science and nutrition.

[14]  David Y. Lai,et al.  PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance , 2003 .

[15]  James E Klaunig,et al.  The Human Relevance of Information on Carcinogenic Modes of Action: Overview , 2003, Critical reviews in toxicology.

[16]  James E Klaunig,et al.  PPARalpha agonist-induced rodent tumors: modes of action and human relevance. , 2003, Critical reviews in toxicology.

[17]  R. Kavet,et al.  Future needs of occupational epidemiology of extremely low frequency electric and magnetic fields: review and recommendations , 2008, Occupational and Environmental Medicine.

[18]  P. Pinsky,et al.  Public Health Service study of Reye's syndrome and medications. Report of the main study. , 1987, JAMA.

[19]  D. Weed Weight of Evidence: A Review of Concept and Methods , 2005, Risk analysis : an official publication of the Society for Risk Analysis.

[20]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[21]  M Susser,et al.  The logic of Sir Karl Popper and the practice of epidemiology. , 1986, American journal of epidemiology.

[22]  K Yamagiwa,et al.  Experimental study of the pathogenesis of carcinoma , 1977, CA: a cancer journal for clinicians.

[23]  Pagona Lagiou,et al.  Causality in cancer epidemiology , 2005, European Journal of Epidemiology.

[24]  E. Dybing,et al.  Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. Proceedings of a consensus conference. Lyon, France, 3-7 November 1997. , 1999, IARC scientific publications.

[25]  R. Koch,et al.  Die Aetiologie der Tuberkulose , 1932, Klinische Wochenschrift.

[26]  A. Aitio,et al.  Human Carcinogens So Far Identified , 1989, Japanese journal of cancer research : Gann.

[27]  Kim Z. Travis,et al.  A proposed framework for the integration of human and animal data in chemical risk assessment , 2008 .

[28]  R. Sarid,et al.  Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). , 2002, Mayo Clinic proceedings.

[29]  L. Haroun,et al.  Identification of Chemicals Carcinogenic to Man , 1984, Toxicologic pathology.

[30]  G. Williams,et al.  Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. , 1996, Pharmacology & therapeutics.

[31]  Jennifer Seed,et al.  Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.

[32]  D. Brusick,et al.  Atrazine and Breast Cancer: A Framework Assessment of the Toxicological and Epidemiological Evidence , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[34]  Carolyn Vickers,et al.  IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .

[35]  R. Koch,et al.  Ueber den augenblicklichen Stand der bakteriologischen Choleradiagnose , 1893, Zeitschrift für Hygiene und Infektionskrankheiten.

[36]  John D. Graham The role of epidemiology in regulatory risk assessment : proceedings of the Conference on the Proper Role of Epidemiology in Risk Analysis, Boston, MA, U.S.A., 13-14 October 1994 , 1995 .

[37]  Carl V Phillips,et al.  Epidemiologic Perspectives & Innovations Open Access the Missed Lessons of Sir Austin Bradford Hill , 2004 .

[38]  S. Greenland,et al.  Causation and causal inference in epidemiology. , 2005, American journal of public health.

[39]  Jennifer Seed,et al.  A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.

[40]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[41]  A. Feinstein,et al.  New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. , 1989, JAMA.

[42]  B. Henderson,et al.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  Leeka Kheifets,et al.  Occupational Electromagnetic Fields and Leukemia and Brain Cancer: An Update to Two Meta-Analyses , 2008, Journal of occupational and environmental medicine.

[44]  Causality and the interpretation of epidemiologic evidence. , 2007, Environmental health perspectives.

[45]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, Annals of Internal Medicine [serial online].

[46]  R. Campbell,et al.  Reye's syndrome and medication use. , 1982, JAMA.

[47]  J. M. Tabuenca TOXIC-ALLERGIC SYNDROME CAUSED BY INGESTION OF RAPESEED OIL DENATURED WITH ANILINE , 1981, The Lancet.

[48]  D. Varma HYDROGEN CYANIDE AND BHOPAL , 1989, The Lancet.

[49]  K F WELLMANN,et al.  [SMOKING AND HEALTH. ON THE REPORT OF THE ADVISORY COMMITTEE TO THE SURGEON GENERAL OF THE PUBLIC HEALTH SERVICE]. , 1964, Deutsche medizinische Wochenschrift.

[50]  Education Welfare.,et al.  Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. , 1964 .